Dr. Becher and the NOAH—AFNET 6 team evaluated the efficacy and safety of anticoagulation with edoxaban in patients with long episodes of device-detected atrial fibrillation lasting 24 hours or ...

Warfarin reduces the risk of stroke in atrial fibrillation by around 60%, while antiplatelet therapy is much less effective. Bleeding is, however, a notable adverse effect with warfarin.

More information: Paulus Kirchhof et al, Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials ...

The annual risk of recurrent ischemic stroke in patients with atrial fibrillation (AF) is about 3.75%, despite around 92% of patients being on oral anticoagulants (OAC). The risk of recurrent stroke ...

Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls. Data Sources: Primary literature was ...

Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated. Risk for recurrent ischemic stroke at 30 days was lower in the early vs. late ...

For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

In this randomized trial, left atrial appendage closure was associated with lower bleeding than oral anticoagulation in patients who underwent catheter-based atrial fibrillation ablation. 2. Left ...

The American Heart Association estimates that atrial fibrillation (AF ... requires a balance between the risks and benefits of oral anticoagulation therapy. Individualized selection of an ...

When it comes to stroke prevention, heart experts now recommend a class of blood thinners called NOACs, or non-vitamin K oral anticoagulants. The newest one approved to treat atrial fibrillation ...